Krka, d. d. (KRK.WA)
PLN 590.0
(0.0%)
PLN 590.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 313.94 Million EUR | -13.58% |
| 2022 | 363.29 Million EUR | 17.49% |
| 2021 | 309.21 Million EUR | 6.26% |
| 2020 | 290.99 Million EUR | 18.51% |
| 2019 | 245.54 Million EUR | 40.64% |
| 2018 | 174.58 Million EUR | 14.41% |
| 2017 | 152.6 Million EUR | 40.71% |
| 2016 | 108.45 Million EUR | -31.47% |
| 2015 | 158.24 Million EUR | -4.8% |
| 2014 | 166.22 Million EUR | -3.83% |
| 2013 | 172.83 Million EUR | 8.08% |
| 2012 | 159.91 Million EUR | -1.77% |
| 2011 | 162.8 Million EUR | -4.81% |
| 2010 | 171.02 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 123.03 Million EUR | 24.43% |
| 2024 Q1 | 98.87 Million EUR | 25.62% |
| 2023 Q3 | 65.27 Million EUR | -19.35% |
| 2023 Q4 | 78.71 Million EUR | 20.59% |
| 2023 FY | 313.94 Million EUR | -13.58% |
| 2023 Q1 | 89.01 Million EUR | 42.77% |
| 2023 Q2 | 80.94 Million EUR | -9.07% |
| 2022 Q1 | 90.39 Million EUR | 32.04% |
| 2022 Q2 | 145.28 Million EUR | 60.73% |
| 2022 Q3 | 65.26 Million EUR | -55.08% |
| 2022 Q4 | 62.35 Million EUR | -4.46% |
| 2022 FY | 363.29 Million EUR | 17.49% |
| 2021 Q2 | 91.5 Million EUR | 5.76% |
| 2021 FY | 309.21 Million EUR | 6.26% |
| 2021 Q3 | 62.72 Million EUR | -31.46% |
| 2021 Q4 | 68.46 Million EUR | 9.15% |
| 2021 Q1 | 86.52 Million EUR | 8.86% |
| 2020 Q4 | 79.48 Million EUR | 57.74% |
| 2020 Q2 | 75.48 Million EUR | -11.85% |
| 2020 Q1 | 85.63 Million EUR | 17.42% |
| 2020 FY | 290.99 Million EUR | 18.51% |
| 2020 Q3 | 50.38 Million EUR | -33.25% |
| 2019 Q3 | 32.48 Million EUR | -53.4% |
| 2019 Q4 | 72.92 Million EUR | 124.51% |
| 2019 Q2 | 69.71 Million EUR | -1.0% |
| 2019 Q1 | 70.41 Million EUR | 31.01% |
| 2019 FY | 245.54 Million EUR | 40.64% |
| 2018 Q3 | 19.05 Million EUR | -63.56% |
| 2018 FY | 174.58 Million EUR | 14.41% |
| 2018 Q2 | 52.29 Million EUR | 5.65% |
| 2018 Q1 | 49.49 Million EUR | 16.34% |
| 2018 Q4 | 53.74 Million EUR | 182.09% |
| 2017 Q3 | 18.39 Million EUR | -62.44% |
| 2017 Q2 | 48.98 Million EUR | 14.76% |
| 2017 Q1 | 42.68 Million EUR | 51.6% |
| 2017 Q4 | 42.54 Million EUR | 131.24% |
| 2017 FY | 152.6 Million EUR | 40.71% |
| 2016 Q2 | 29.89 Million EUR | -25.51% |
| 2016 FY | 108.45 Million EUR | -31.47% |
| 2016 Q1 | 40.13 Million EUR | 61.35% |
| 2016 Q4 | 28.15 Million EUR | 174.0% |
| 2016 Q3 | 10.27 Million EUR | -65.63% |
| 2015 Q1 | 55.11 Million EUR | 42.0% |
| 2015 Q2 | 57.19 Million EUR | 3.76% |
| 2015 FY | 158.24 Million EUR | -4.8% |
| 2015 Q4 | 24.87 Million EUR | 18.07% |
| 2015 Q3 | 21.06 Million EUR | -63.17% |
| 2014 FY | 166.22 Million EUR | -3.83% |
| 2014 Q2 | 64.06 Million EUR | 50.6% |
| 2014 Q4 | 38.81 Million EUR | 86.67% |
| 2014 Q3 | 20.79 Million EUR | -67.54% |
| 2014 Q1 | 42.54 Million EUR | -11.27% |
| 2013 Q3 | 24.55 Million EUR | -49.85% |
| 2013 Q4 | 47.94 Million EUR | 95.28% |
| 2013 FY | 172.83 Million EUR | 8.08% |
| 2013 Q1 | 51.37 Million EUR | 6.21% |
| 2013 Q2 | 48.95 Million EUR | -4.71% |
| 2012 Q4 | 48.37 Million EUR | 125.3% |
| 2012 Q2 | 41.42 Million EUR | -14.84% |
| 2012 Q1 | 48.64 Million EUR | 2.72% |
| 2012 FY | 159.91 Million EUR | -1.77% |
| 2012 Q3 | 21.47 Million EUR | -48.17% |
| 2011 FY | 162.8 Million EUR | -4.81% |
| 2011 Q4 | 47.35 Million EUR | 0.0% |
| 2010 FY | 171.02 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Celon Pharma S.A. | -28.12 Million PLN | 1216.292% |